

[ Sat, Apr 26th
] - SNY
[ Sat, Apr 26th
] - TheHealthSite
[ Sat, Apr 26th
] - MyNewsLA
[ Sat, Apr 26th
] - PBS
[ Sat, Apr 26th
] - WPBF

[ Fri, Apr 25th
] - WSOC
[ Fri, Apr 25th
] - KUNC
[ Fri, Apr 25th
] - People
[ Fri, Apr 25th
] - Insider
[ Fri, Apr 25th
] - Fortune
[ Fri, Apr 25th
] - WLKY
[ Fri, Apr 25th
] - Investopedia
[ Fri, Apr 25th
] - deseret
[ Fri, Apr 25th
] - MoneyWeek
[ Fri, Apr 25th
] - koaa
[ Fri, Apr 25th
] - Kiplinger
[ Fri, Apr 25th
] - CNN
[ Fri, Apr 25th
] - Marketplace
[ Fri, Apr 25th
] - AFP
[ Fri, Apr 25th
] - HuffPost
[ Fri, Apr 25th
] - Deadline
[ Fri, Apr 25th
] - Deadline
[ Fri, Apr 25th
] - InStyle
[ Fri, Apr 25th
] - WDRB
[ Fri, Apr 25th
] - PhoneArena
[ Fri, Apr 25th
] - Pitchfork
[ Fri, Apr 25th
] - KIRO
[ Fri, Apr 25th
] - Billboard
[ Fri, Apr 25th
] - KXAN
[ Fri, Apr 25th
] - WJZY
[ Fri, Apr 25th
] - Variety
[ Fri, Apr 25th
] - NewsNation
[ Fri, Apr 25th
] - Cosmopolitan
[ Fri, Apr 25th
] - TechCrunch
[ Fri, Apr 25th
] - CNN
[ Fri, Apr 25th
] - MarketWatch
[ Fri, Apr 25th
] - WWD
[ Fri, Apr 25th
] - fingerlakes1
[ Fri, Apr 25th
] - CNN
[ Fri, Apr 25th
] - OPB
[ Fri, Apr 25th
] - MassLive
[ Fri, Apr 25th
] - bjpenn
[ Fri, Apr 25th
] - CNN
[ Fri, Apr 25th
] - news4sanantonio
[ Fri, Apr 25th
] - TechRadar
[ Fri, Apr 25th
] - Fortune
[ Fri, Apr 25th
] - Forbes
[ Fri, Apr 25th
] - inforum
[ Fri, Apr 25th
] - cnbctv18
[ Fri, Apr 25th
] - cnbctv18
[ Fri, Apr 25th
] - Time
[ Fri, Apr 25th
] - Bloomberg
[ Fri, Apr 25th
] - fingerlakes1
[ Fri, Apr 25th
] - BBC
[ Fri, Apr 25th
] - WOPRAI
[ Fri, Apr 25th
] - WLRN
[ Fri, Apr 25th
] - Fortune
[ Fri, Apr 25th
] - CNBC
[ Fri, Apr 25th
] - WOPRAI
[ Fri, Apr 25th
] - WOPRAI
[ Fri, Apr 25th
] - Oregonian
[ Fri, Apr 25th
] - MSNBC
[ Fri, Apr 25th
] - WOPRAI
[ Fri, Apr 25th
] - WOPRAI
[ Fri, Apr 25th
] - Fortune
[ Fri, Apr 25th
] - Eurogamer
[ Fri, Apr 25th
] - WOPRAI
[ Fri, Apr 25th
] - WOPRAI
[ Fri, Apr 25th
] - WOPRAI
[ Fri, Apr 25th
] - WOPRAI
[ Fri, Apr 25th
] - WOPRAI
[ Fri, Apr 25th
] - NextShark
[ Fri, Apr 25th
] - People
[ Fri, Apr 25th
] - KUTV
[ Fri, Apr 25th
] - WOPRAI
[ Fri, Apr 25th
] - Impacts
[ Fri, Apr 25th
] - Fortune
[ Fri, Apr 25th
] - KTVX
[ Fri, Apr 25th
] - WOPRAI
[ Fri, Apr 25th
] - WOPRAI
[ Fri, Apr 25th
] - WOPRAI
[ Fri, Apr 25th
] - WOPRAI
[ Fri, Apr 25th
] - WOPRAI
[ Fri, Apr 25th
] - WOPRAI
[ Fri, Apr 25th
] - WOPRAI
[ Fri, Apr 25th
] - WOPRAI
[ Fri, Apr 25th
] - wjla
[ Fri, Apr 25th
] - CoinTelegraph
[ Fri, Apr 25th
] - WOPRAI
[ Fri, Apr 25th
] - Forbes
[ Fri, Apr 25th
] - Oregonian
[ Fri, Apr 25th
] - AZOM
[ Fri, Apr 25th
] - ZDNet
[ Fri, Apr 25th
] - ThePrint
Gilead Sciences Stock Falls as Slumping COVID-19, Cancer Drug Sales Hit Revenue
- Gilead Sciences missed first-quarter revenue estimates as sales of its COVID-19 and cancer drugs declined.

Read the Full Investopedia Article at:
[ https://www.investopedia.com/gilead-sciences-stock-falls-as-slumping-covid-19-cancer-drug-sales-hit-revenue-11721926 ]